Health ❯ Healthcare ❯ Cancer Research

Biomarkers

PD-L1 Toxicity Management Treatment Efficacy MGMT-unmethylated Glioblastoma Prognostic Biomarkers Patient Data TROP2 Expression Deep Learning HER2 and CD24 Circulating Tumor DNA (ctDNA) Personalized Medicine Lynch Syndrome HRR Gene Alterations Circulating Biomarkers Alpha-fetoprotein Circulating Tumor Cells p53 Protein

AI Pathomics Tool Beats PD-L1 at Predicting Lung Cancer Immunotherapy Benefit

The biology-guided system uses routine pathology slides to give clearer guidance than PD-L1 on who benefits from immunotherapy.

Pediatric Germ Cell Tumors Show Distinct Immune Profiles, Pointing to New Targets

Preclinical Study Highlights HER2 and CD24 as Radiotheranostic Targets in Endometrial Cancer

High-Dose Steroids Undermine Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Capsule Sponge Test Could Replace Endoscopies for Over Half of Barrett’s Oesophagus Patients